Pace Diagnostics

Pace Diagnostics

Early Stage

Revolutionary point-of-care, affordable early detection Lung cancer and Tuberculosis diagnostics

Revolutionary point-of-care, affordable early detection Lung cancer and Tuberculosis diagnostics

Overview

Raised to Date: Raised: $143,140

Total Commitments ($USD)

Platform

Wefunder

Start Date

12/02/2021

Close Date

12/30/2022

Min. Goal
$50,000
Max. Goal
$250,000
Min. Investment

$200

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Early Bird Val. Cap

$18,000,000

Valuation Cap

$20,000,000

Discount

20%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

12/31/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$365

# of Investors

125

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Location

Monrovia, California

Business Type

Growth

Pace Diagnostics, with a valuation of $20 million, is raising funds on Wefunder. The diagnostics company provides quick, affordable, and accurate tests for lung cancer and tuberculosis. The point-of-care diagnostics of Pace Diagnostics will help save millions of lives through quick screening and preventative healthcare. Pace Diagnostics has won grants from the US DoD, NIH, and NSF and also aims to distribute its product in EU countries. Marianne Nguyen, Lorne Mattner, Hiep Hoa Nguyen, Sanjay Jayachandran, and Victoria Nguyen founded Pace Diagnostics in September 2017. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $250,000. The campaign proceeds will be used for advertisement and promotions, manufacturing, marketing, hiring, and research development.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-437,662

$-976,888

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$52,368

$58,267

Accounts Receivable

$6

$353

Total Assets

$508,730

$536,496

Short-Term Debt

$626,418

$216,578

Long-Term Debt

$0

$0

Total Liabilities

$626,418

$216,578

Financials as of: 12/02/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Pace Diagnostics on Wefunder 2021
Platform: Wefunder
Security Type: SAFE
Valuation: $20,000,000

Follow company

Follow Pace Diagnostics on Wefunder 2021

Buy Pace Diagnostics's Deal Report

Warning: according to the close date for this deal, Pace Diagnostics may no longer be accepting investments.

Pace Diagnostics Deal Report

Get KingsCrowd’s comprehensive report on Pace Diagnostics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Pace Diagnostics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Pace Diagnostics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge